• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Mirati - oncology?

Quote
His kids are out of the house by now (college and beyond),
The more surprisingly thing is the Intel about the trip and number of members.
This must be coming from someone really close to him. I guess this illustrates he really sucked as a leader and even those “close” to him were just playing along….
 




































It would be wise for the enlightened to sharpen your resumes.
When the full quarter sales for adagrasib are announced in April, be prepared for a significant reduction in work force.
Leadership will strip all “non-essential” workforce to prepare for an acquisition or merger.

If you see this as an opportunity from a stock pricing perspective, you are sorely misguided. The price will be bargain basement at best. Don't worry though. Leadership will do very well for themselves....
 












anonymous said:
It would be wise for the enlightened to sharpen your resumes.
When the full quarter sales for adagrasib are announced in April, be prepared for a significant reduction in work force.
Leadership will strip all “non-essential” workforce to prepare for an acquisition or merger.

If you see this as an opportunity from a stock pricing perspective, you are sorely misguided. The price will be bargain basement at best. Don't worry though. Leadership will do very well for themselves....
Click to expand...

That was always Meek’s plan in coming here. He thought he was going to get rich when he went to Fergene but that imploded before he could cash out. This is his second at bat to become a biotech millionaire. He doesn’t give a shit about anything else (or you).
 
































Top Bottom
Back
Quote